JP2012505178A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012505178A5 JP2012505178A5 JP2011530475A JP2011530475A JP2012505178A5 JP 2012505178 A5 JP2012505178 A5 JP 2012505178A5 JP 2011530475 A JP2011530475 A JP 2011530475A JP 2011530475 A JP2011530475 A JP 2011530475A JP 2012505178 A5 JP2012505178 A5 JP 2012505178A5
- Authority
- JP
- Japan
- Prior art keywords
- ruminant
- dopamine receptor
- composition
- administered
- agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 16
- 239000000203 mixture Substances 0.000 claims 12
- 241000282849 Ruminantia Species 0.000 claims 10
- 239000000556 agonist Substances 0.000 claims 6
- 230000001263 anti-prolactin effect Effects 0.000 claims 6
- AWFDCTXCTHGORH-HGHGUNKESA-N 6-[4-[(6ar,9r,10ar)-5-bromo-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline-9-carbonyl]piperazin-1-yl]-1-methylpyridin-2-one Chemical group O=C([C@H]1CN([C@H]2[C@@H](C=3C=CC=C4NC(Br)=C(C=34)C2)C1)C)N(CC1)CCN1C1=CC=CC(=O)N1C AWFDCTXCTHGORH-HGHGUNKESA-N 0.000 claims 5
- 239000003136 dopamine receptor stimulating agent Substances 0.000 claims 5
- 102000015554 Dopamine receptor Human genes 0.000 claims 3
- 108050004812 Dopamine receptor Proteins 0.000 claims 3
- 230000006651 lactation Effects 0.000 claims 3
- 229940098778 Dopamine receptor agonist Drugs 0.000 claims 2
- 210000000481 breast Anatomy 0.000 claims 2
- 230000002500 effect on skin Effects 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 239000008267 milk Substances 0.000 claims 2
- 210000004080 milk Anatomy 0.000 claims 2
- 235000013336 milk Nutrition 0.000 claims 2
- GDFGTRDCCWFXTG-SCTDSRPQSA-N (3r,4ar,10as)-3-(diethylsulfamoylamino)-6-hydroxy-1-propyl-3,4,4a,5,10,10a-hexahydro-2h-benzo[g]quinoline Chemical compound C1=CC=C2C[C@@H]3N(CCC)C[C@H](NS(=O)(=O)N(CC)CC)C[C@H]3CC2=C1O GDFGTRDCCWFXTG-SCTDSRPQSA-N 0.000 claims 1
- 206010000234 Abortion spontaneous Diseases 0.000 claims 1
- 241000283690 Bos taurus Species 0.000 claims 1
- KORNTPPJEAJQIU-KJXAQDMKSA-N Cabaser Chemical group C1=CC([C@H]2C[C@H](CN(CC=C)[C@@H]2C2)C(=O)N(CCCN(C)C)C(=O)NCC)=C3C2=CNC3=C1 KORNTPPJEAJQIU-KJXAQDMKSA-N 0.000 claims 1
- 241000282832 Camelidae Species 0.000 claims 1
- 241000283707 Capra Species 0.000 claims 1
- 241001494479 Pecora Species 0.000 claims 1
- BKRGVLQUQGGVSM-KBXCAEBGSA-N Revanil Chemical compound C1=CC(C=2[C@H](N(C)C[C@H](C=2)NC(=O)N(CC)CC)C2)=C3C2=CNC3=C1 BKRGVLQUQGGVSM-KBXCAEBGSA-N 0.000 claims 1
- 230000002411 adverse Effects 0.000 claims 1
- 208000030270 breast disease Diseases 0.000 claims 1
- 229960002802 bromocriptine Drugs 0.000 claims 1
- OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 claims 1
- 229960004596 cabergoline Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 244000038280 herbivores Species 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 229960003587 lisuride Drugs 0.000 claims 1
- 208000004396 mastitis Diseases 0.000 claims 1
- 229960004650 metergoline Drugs 0.000 claims 1
- WZHJKEUHNJHDLS-QTGUNEKASA-N metergoline Chemical compound C([C@H]1CN([C@H]2[C@@H](C=3C=CC=C4N(C)C=C(C=34)C2)C1)C)NC(=O)OCC1=CC=CC=C1 WZHJKEUHNJHDLS-QTGUNEKASA-N 0.000 claims 1
- 208000015994 miscarriage Diseases 0.000 claims 1
- FASDKYOPVNHBLU-ZETCQYMHSA-N pramipexole Chemical compound C1[C@@H](NCCC)CCC2=C1SC(N)=N2 FASDKYOPVNHBLU-ZETCQYMHSA-N 0.000 claims 1
- 229960003089 pramipexole Drugs 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 229960000924 quinagolide Drugs 0.000 claims 1
- UHSKFQJFRQCDBE-UHFFFAOYSA-N ropinirole Chemical group CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2 UHSKFQJFRQCDBE-UHFFFAOYSA-N 0.000 claims 1
- 229960001879 ropinirole Drugs 0.000 claims 1
- 229960003179 rotigotine Drugs 0.000 claims 1
- KFQYTPMOWPVWEJ-INIZCTEOSA-N rotigotine Chemical compound CCCN([C@@H]1CC2=CC=CC(O)=C2CC1)CCC1=CC=CS1 KFQYTPMOWPVWEJ-INIZCTEOSA-N 0.000 claims 1
- 208000000995 spontaneous abortion Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0805544A FR2936710B1 (fr) | 2008-10-07 | 2008-10-07 | Composition veterinaire antiprolactinique destinee aux ruminants |
| FR0805544 | 2008-10-07 | ||
| PCT/EP2009/063004 WO2010040765A1 (fr) | 2008-10-07 | 2009-10-07 | Composition veterinaire antiprolactinique destinee aux ruminants |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012505178A JP2012505178A (ja) | 2012-03-01 |
| JP2012505178A5 true JP2012505178A5 (enExample) | 2012-06-07 |
| JP5955561B2 JP5955561B2 (ja) | 2016-07-20 |
Family
ID=40527505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011530475A Active JP5955561B2 (ja) | 2008-10-07 | 2009-10-07 | 反芻動物のための獣医用抗プロラクチン組成物 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US9730923B2 (enExample) |
| EP (1) | EP2349272B1 (enExample) |
| JP (1) | JP5955561B2 (enExample) |
| KR (2) | KR20110110091A (enExample) |
| CN (1) | CN102215843B (enExample) |
| AU (1) | AU2009301134B2 (enExample) |
| BR (1) | BRPI0914064A2 (enExample) |
| CA (1) | CA2738875C (enExample) |
| DK (1) | DK2349272T3 (enExample) |
| ES (1) | ES2719844T3 (enExample) |
| FR (1) | FR2936710B1 (enExample) |
| HU (2) | HUE043239T2 (enExample) |
| IL (1) | IL212125B (enExample) |
| MA (1) | MA32763B1 (enExample) |
| MX (1) | MX2011003743A (enExample) |
| NO (1) | NO2019028I1 (enExample) |
| NZ (1) | NZ592288A (enExample) |
| PL (1) | PL2349272T3 (enExample) |
| PT (1) | PT2349272T (enExample) |
| RU (1) | RU2528892C2 (enExample) |
| SI (1) | SI2349272T1 (enExample) |
| UA (1) | UA103779C2 (enExample) |
| WO (1) | WO2010040765A1 (enExample) |
| ZA (1) | ZA201103273B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2971423B1 (fr) | 2011-02-15 | 2014-01-10 | Ceva Sante Animale | Composition veterinaire antiprolactinique destinee aux ruminants |
| EP2995297A1 (fr) * | 2014-09-09 | 2016-03-16 | Ceva Sante Animale | Compositions parentérales et leurs utilisations |
| CN109963593B (zh) | 2016-11-29 | 2023-02-28 | 国立研究开发法人国立精神·神经医疗研究中心 | 进展型免疫性脱髓鞘病的预防、发病抑制或治疗剂 |
| US12459965B2 (en) | 2017-10-09 | 2025-11-04 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| JP2022529353A (ja) | 2019-04-17 | 2022-06-21 | コンパス パスファインダー リミテッド | 神経認知障害、慢性疼痛を治療し、炎症を低減させる方法 |
| AU2020394498A1 (en) | 2019-11-28 | 2022-06-09 | Boehringer Ingelheim Vetmedica Gmbh | Use of SGLT-2 inhibitors in the drying-off of non-human mammals |
| AR122365A1 (es) * | 2020-01-27 | 2022-09-07 | Ceva Sante Animale | Composición veterinaria de anti-prolactina para rumiantes utilizada mediante administración intramamaria |
| UY39019A (es) * | 2020-01-27 | 2021-07-30 | Ceva Sante Animale | Composición veterinaria para rumiantes lecheros para el tratamiento de la fiebre de la leche |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4839171A (en) * | 1984-11-30 | 1989-06-13 | Techmix, Inc. | Composition for treating impaired lactation |
| US4939259A (en) * | 1989-07-24 | 1990-07-03 | Eli Lilly And Company | 2-oxo-pyrido[2,3-g]quinoline derivatives |
| AU2635599A (en) * | 1999-03-17 | 2000-10-04 | Eugen Eigenmann | Use of prolactin inhibitors for the treatment of fertility problems in animal species |
| GB0108485D0 (en) * | 2001-04-04 | 2001-05-23 | Pfizer Ltd | Combination therapy |
| NZ515178A (en) * | 2001-11-23 | 2004-09-24 | Agres Ltd | Modulating prolactin receptors to affect a physiological response |
| GB0313892D0 (en) * | 2003-06-16 | 2003-07-23 | Hannah Res Inst | Control of lactation |
| GB0314469D0 (en) | 2003-06-20 | 2003-07-23 | Phico Therapeutics Ltd | Antimicrobial compositions and uses thereof |
| CN1762495B (zh) * | 2004-09-21 | 2011-04-06 | 山东绿叶制药有限公司 | 含有多巴胺受体激动剂类药物的长效缓释制剂及其制备工艺 |
| PL1797871T3 (pl) * | 2004-09-21 | 2015-07-31 | Shandong luye pharmaceutical co ltd | Długo działający preparat o przedłużonym uwalnianiu zawierający agonistę receptora dopaminowego i sposób jego wytwarzania |
| EP1952813A1 (en) * | 2007-02-01 | 2008-08-06 | Ferring International Center S.A. | Medicament for the treatment of endometriosis |
| ITTO20070479A1 (it) * | 2007-07-02 | 2009-01-03 | Ceva Vetem S P A | Composizione veterinaria iniettabile ad attivita' anti-prolattinica |
-
2008
- 2008-10-07 FR FR0805544A patent/FR2936710B1/fr active Active
-
2009
- 2009-10-07 CN CN200980145820.7A patent/CN102215843B/zh active Active
- 2009-10-07 ES ES09783801T patent/ES2719844T3/es active Active
- 2009-10-07 EP EP09783801.5A patent/EP2349272B1/fr active Active
- 2009-10-07 PL PL09783801T patent/PL2349272T3/pl unknown
- 2009-10-07 CA CA2738875A patent/CA2738875C/fr active Active
- 2009-10-07 BR BRPI0914064A patent/BRPI0914064A2/pt not_active Application Discontinuation
- 2009-10-07 KR KR1020117009774A patent/KR20110110091A/ko not_active Ceased
- 2009-10-07 HU HUE09783801A patent/HUE043239T2/hu unknown
- 2009-10-07 DK DK09783801.5T patent/DK2349272T3/da active
- 2009-10-07 WO PCT/EP2009/063004 patent/WO2010040765A1/fr not_active Ceased
- 2009-10-07 RU RU2011118366/15A patent/RU2528892C2/ru active
- 2009-10-07 KR KR1020177002975A patent/KR101892559B1/ko active Active
- 2009-10-07 JP JP2011530475A patent/JP5955561B2/ja active Active
- 2009-10-07 UA UAA201105713A patent/UA103779C2/ru unknown
- 2009-10-07 SI SI200931957T patent/SI2349272T1/sl unknown
- 2009-10-07 PT PT09783801T patent/PT2349272T/pt unknown
- 2009-10-07 AU AU2009301134A patent/AU2009301134B2/en active Active
- 2009-10-07 MX MX2011003743A patent/MX2011003743A/es active IP Right Grant
- 2009-10-07 NZ NZ592288A patent/NZ592288A/xx unknown
-
2011
- 2011-04-04 IL IL212125A patent/IL212125B/en active IP Right Grant
- 2011-04-07 US US13/081,671 patent/US9730923B2/en active Active
- 2011-05-02 MA MA33803A patent/MA32763B1/fr unknown
- 2011-05-05 ZA ZA2011/03273A patent/ZA201103273B/en unknown
-
2013
- 2013-03-14 US US13/828,023 patent/US9744158B2/en active Active
-
2019
- 2019-07-05 NO NO2019028C patent/NO2019028I1/no unknown
- 2019-07-08 HU HUS1900036C patent/HUS1900036I1/hu unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012505178A5 (enExample) | ||
| RU2011118366A (ru) | Ветеринарная антипролактиновая композиция для жвачных | |
| JP2009298801A5 (enExample) | ||
| JP2023503437A (ja) | 非ヒト動物の乾乳におけるｓｇｌｔ－２阻害剤の使用 | |
| Van Wettere et al. | Effect of oral polyamine supplementation pre-weaning on piglet growth and intestinal characteristics | |
| RU2014102944A (ru) | Композиция вакцины для трансдермального или трансмукозального введения | |
| US20140024670A1 (en) | Veterinary anti-prolactin composition for ruminants | |
| JP7154384B2 (ja) | 乳牛の乾乳における経口ボーラスの使用 | |
| Daels | Induction of lactation and adoption of the orphan foal | |
| RU2016116810A (ru) | Ветеринарный способ индукции рвоты | |
| JP2012513411A5 (enExample) | ||
| JP6556526B2 (ja) | モサプリドクエン酸塩におけるウシの消化器疾患の予防剤または治療剤 | |
| RU2283648C2 (ru) | Новое применение комбинированных селективных антагонистов допаминового рецептора d2 и агонистов рецептора 5-нт 1a | |
| WO2007061868A2 (en) | Treatment of stereotypic, self-injurious and compulsive behaviors using specific serotonin reuptake inhibitors and antagonists of nmda receptors | |
| H Najafzadeh | Determination of furazolidone residues in muscles of the cultured common carp following experimental bath and oral administration | |
| Subarna Kundu et al. | Successful treatment of cracked hooves in post Fmd complication in cattle. | |
| Suman et al. | Residual Effect of Experimental Advocation of Levofloxacin in Broiler Birds | |
| Indrová et al. | Biochemical changes in follicular fluid and venous blood during acute ruminal acidosis in heifers | |
| AR122365A1 (es) | Composición veterinaria de anti-prolactina para rumiantes utilizada mediante administración intramamaria | |
| KR101823378B1 (ko) | 경화유지로 코팅된 인도메타신을 포함하는 비육 촉진용 조성물 및 이의 용도 | |
| RU2009111098A (ru) | Способ лечения алкогольной, опийной и табачной зависимости "универсальный психофармакологический нейрофизиологический блок" | |
| Obber et al. | Clinical Dictyocaulus infection in cattle grazing in Belluno province (Eastern Alps-Italy). | |
| Marzok et al. | Use of romifidine in dromedary camels. | |
| SS | Effects of oral administration of monensin on serum glucose, AST, and arginase of holstein cows during transition period |